|
||
ARTICLE |
Correspondence to Tzyh-Chang Hwang: hwangt{at}health.missouri.edu
|
|
|---|
Abbreviations used in this paper: CFTR, cystic fibrosis transmembrane conductance regulator; P-ATP, N6-(2-phenylethyl)-ATP; WT, wild type.
| INTRODUCTION |
|---|
|
|
|---|
Ideally, to understand the roles of CFTR's two NBDs, one needs to manipulate the ligand binding affinity at each NBD by mutating amino acid residues that interact with ATP in the binding pockets and/or by chemically engineering ATP to alter its affinity. These strategies have been successfully employed in other ATP binding proteins (e.g., Shah et al., 1997
; Gillespie et al., 1999
). Recent success in solving the crystal structures of CFTR's NBD1 (Lewis et al., 2004
; Lewis et al., 2005
) and in designing high-affinity hydrolyzable ATP analogues for CFTR gating (Zhou et al., 2005
) has made structure-guided functional studies possible for the first time in the CFTR field. A good example is the utilization of homology modeling of NBDs and mutant cycle analysis to demonstrate that the opening of the CFTR channels is associated with the dimerization of CFTR's two NBDs (Vergani et al., 2005
).
Capitalizing on the crystal structures of CFTR's NBD1, we made mutations of the aromatic residues that interact (or are predicted to interact) with the adenine ring of ATP in CFTR's NBD1 (tryptophan 401, i.e., W401) and NBD2 (tyrosine 1219, i.e., Y1219). Macroscopic and microscopic kinetic analyses of ATP-dependent gating reveal functional asymmetry of these two ATP binding sites. Nonconserved mutations of Y1219 cause a rightward shift of the relationship between [ATP] and the opening rate, suggesting that ATP binding at the NBD2 site plays a critical role in channel opening. Although conversion of W401 to glycine (i.e., W401G) has little effect on the sensitivity of the channel opening rate to [ATP], this mutation shortens the mean open time. The shortening of the open time by the W401G mutation is also seen with the hydrolysis-deficient mutant background (i.e., E1371S), suggesting that the effect of W401G mutation is not through a perturbation of ATP hydrolysis. Kinetic and energetic asymmetry of CFTR's two ATP binding sites will be discussed.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Electrophysiological Recordings
Inside-out patch-clamp recordings were performed according to methods described previously (e.g., Zhou et al., 2002
). In brief, the pipette solution (i.e., extracellular solution) contained (in mM) 140 NMDG-Cl, 2 MgCl2, 5 CaCl2, and 10 HEPES (pH 7.4 with NMDG). Cells were perfused with a bath solution containing (in mM) 145 NaCl, 5 KCl, 2 MgCl2, 1 CaCl2, 5 glucose, 5 HEPES, and 20 sucrose (pH 7.4 with NaOH). After the establishment of an inside-out configuration, the patch was perfused with a standard perfusion solution (i.e., intracellular solution) containing (in mM) 150 NMDG-Cl, 2 MgCl2, 10 EGTA, and 8 Tris (pH 7.4 with NMDG). Patches were held at 50 mV in all experiments. Downward deflections of the current trace represent channel opening. Currents were recorded at room temperature using an EPC10 patch-clamp amplifier (Heka Electronic). Current traces were filtered at 100 Hz with a built-in 4-pole Bessel filter and digitized online at 500 Hz.
Data Analysis
Steady-state macroscopic current amplitude, used for construction of the ATP doseresponse relationship, was measured using Igor Pro program (version 4.07; Wavemetrics). Specifically, the mean current amplitude was measured as an average of all data points from
1 min of continuous recording. The mean baseline current was measured in the same way and then subtracted. Only recordings from patches containing no more than eight channels (estimated from maximal number of simultaneous openings during at least 20 min of recording) were selected for single-channel kinetic analysis. These data were further filtered at 50 Hz and analyzed using software written by Dr. Csanády (2000)
. A three-state kinetic model, C
O
B, was adopted to extract kinetic parameters as described previously (Csanády et al., 2000
; Vergani et al., 2003
; Bompadre et al., 2005a
). To estimate the time constant of current relaxation, a single exponential function was fitted to the data using Igor Pro program. The first 5 s of the current relaxation were excluded from curve fitting due to the limited speed of solution exchange.
All averaged data are presented as means ± SEM.; n represents the number of experiments. Student t tests were performed using SigmaPlot (version 8.0), and results were considered significant when P < 0.05.
Homology Modeling of Human CFTR NBD2
The modeled structure was generated by using the program MODELLER. The crystal structure of human F508A NBD1-ATP complexes (pdb code: 1xmi, chain A) was used as a template. Y1219 was aligned to W401 (also see Callebaut et al., 2004
; Moran et al., 2005
). The ATP molecule was included in the modeled structure.
Online Supplemental Material
The online supplemental material (text and Fig. S1) is available at http://www.jgp.org/cgi/content/full/jgp.200609622/DC1. The online supplement shows our energetic analysis of the closing rate for hydrolysis-deficient mutants.
| RESULTS |
|---|
|
|
|---|
|
80% of maximal current for WT, only elicits a small fraction of current compared with that by 20 mM ATP, the highest [ATP] tested. Fig. 1 D summarizes normalized macroscopic ATP doseresponse relationships of WT, W401G, and Y1219G. Although the W401G mutation does not affect the apparent affinity, converting Y1219 to glycine causes a dramatic rightward shift of the ATP doseresponse curve with a K1/2 of 4.72 ± 1.12 mM, >50-fold higher than that of WT (0.09 ± 0.02 mM). We further characterized several mutations at the Y1219 residue (Fig. 2 A). A more conserved mutation (Y1219W) does not change the K1/2 value significantly. The ATP doseresponse relationships of Y1219F and Y1219I mutants lie between those of WT and Y1219G. These results suggest that observed changes of the ATP sensitivity are not due to a nonspecific mutational effect. Since the macroscopic ATP doseresponse mostly reflects the potency of ATP in opening the channel, we hypothesize that ATP binding at the NBD2 site plays a critical role in channel opening.
|
10 mM ATP. The opening rate of Y1219I at 10 or 20 mM ATP is very similar to that of WT at 2.75 mM ATP (Fig. 2, B and C), indicating that mutations at the Y1219 residue likely affect the ATP binding step with minimal effect on the post-binding events. Fig. 2 C shows the relationship between the opening rate and [ATP] for WT, W401G, Y1219I, and Y1219G. It should be noted that these relationships virtually mirror the macroscopic ATP doseresponse relationship (Fig. 2 A), consistent with the notion that the opening rate is the major determinant for the macroscopic ATP doseresponse curve (Zeltwanger et al., 1999
It is known that the opening rate of CFTR is very sensitive to the influence of PKA-dependent phosphorylation (Mathews et al., 1998
; Wang et al., 1998
). Before we draw the conclusion that these mutational effects at the Y1219 residue result from a perturbation of ATP binding at the NBD2 site, we need to rule out the possibility that mutations at the Y1219 residue somehow hinder phosphorylation of the R domain, and thus the observed decrease of the opening rate is secondary to a potential mutational effect on phosphorylation. To exclude this possibility, we introduced the mutations of interest into a CFTR construct with the entire R domain deleted (
R-CFTR) (Csanády et al., 2000
). We have extensively characterized this phosphorylation-independent CFTR channel and shown that its ATP sensitivity and single-channel kinetic parameters are very similar to those of WT CFTR (Bompadre et al., 2005a
). Fig. 2 D shows a similar rightward shift of the ATP doseresponse relationships for Y1219I and Y1219G mutants under the
R-CFTR background. These results strongly support the hypothesis that ATP binding at the NBD2 site catalyzes channel opening.
Although mutations of the W401 residue at the NBD1 site had minimal effect on the relationship between [ATP] and the opening rate (Fig. 2, B and C), close inspection of the single-channel current trace reveals that the channel open time is shorter for the W401G mutant (Fig. 2 B). Fig. 3 A summarizes the mean open time for WT, W401G, and Y1219G.
Although the Y1219G mutation causes a dramatic change of the relationship between [ATP] and the opening rate, it has negligible effect on the mean open time. In contrast, W401G exhibits
40% decrease of the mean open time, suggesting that mutations that decrease the ATP binding affinity at the NBD1 site destabilize the open channel conformation (i.e., increase the closing rate). It should be noted that this shortening of the mean open time by W401G mutant is not readily reflected in the ATP doseresponse relationship (Fig. 1 D). Indeed, according to our simulation, if the relationship between the opening rate and [ATP] remains unchanged, a 40% shortening of the mean open time only results in
15% change of the apparent Kd, which is within the experimental error range (Fig. 1 D, legend).
|
To examine the potential effect of mutation in NBD1 on ATP hydrolysis at NBD2, we introduced the W401G mutation into the E1371S background, a mutant CFTR whose ATP hydrolysis is abolished (Moody et al., 2002
; Tombline et al., 2004
; Vergani et al., 2005
). If the shortened open time seen with the W401G mutant is indeed due to an increased ATP hydrolysis rate, the effect on the open time should be at least reduced once the ATP hydrolysis is eliminated. Since the gating cycle of channels in the E1371S background is extremely long, it is technically difficult to do microscopic single-channel kinetic analysis. We, therefore, resorted to macroscopic current relaxation experiments, which has been used previously to assess the mean open time of hydrolysis-deficient CFTR channels (Vergani et al., 2003
, 2005
; Bompadre et al., 2005a
). It should be noted that the relaxation time constant upon withdrawal of ATP is determined by the channel closing rate, opening rate, and the ATP dissociation rate if a simply ligand-gated kinetic scheme is assumed. However, since the ATP dissociation rate is much faster than the channel opening rate and closing rate, this relaxation time constant reflects mainly the closing rate of the channel (see online supplemental material for detail, available at http://www.jgp.org/cgi/content/full/jgp.200609622/DC1). Fig. 3 B shows experiments using current relaxation analysis to estimate the open time constants for E1371S and W401G/E1371S. Our results show that the relaxation time constant for W401G/E1371S (59.1 ± 4.6 s, n = 8) is shortened by
50%, compared with that of E1371S (111.7 ± 12.1 s, n = 15) (Fig. 3 C), suggesting that the shorter open time of W401G is not secondary to an altered ATP hydrolysis rate. In contrast, although the Y1219G mutation greatly decreases the apparent affinity of ATP (Fig. 2 C), introducing this mutation into the E1371S background has little effect on the relaxation time constant (107.6 ± 12.4 s, n = 7) (Fig. 3, B and C). In addition, W401G/Y1219G/E1371S has a relaxation time constant of 49.0 ± 5.3 s (Fig. 3, B and C), which is similar to that of W401G/E1371S, indicating that W401, but not Y1219, plays a dominant role in modulating the open time.
Although we cannot rule out the possibility of an allosteric effect of mutations on the stability of the open state, the following results are more in line with the idea that it is the binding energy of ATP that determines the stability of the open state. First, it has been shown that mutations at the K464 residue (Fig. 1 A) decrease ATP binding affinity at the NBD1 site (Basso et al., 2003
) and shorten the open time (Carson et al., 1995
; Gunderson and Kopito, 1995
; Sugita et al., 1998
; Powe et al., 2002
; compare with Vergani et al., 2003
). Second, we have recently characterized the effects of an ATP analogue, N6-(2-phenylethyl)-ATP (denoted as P-ATP), on CFTR gating. Not only is P-ATP >50-fold more potent than ATP in opening CFTR, it also increases the open time by
30% (Fig. 4 A; also see Zhou et al., 2005
). Third, the shortened relaxation time constant due to the W401G mutation can be prolonged by P-ATP (see below).
The idea that ATP binding at the NBD1 site stabilizes the open channel conformation is also supported by the recent report by Csanády et al. (2005)
An interesting feature revealed by the comparison of NBD1 and NBD2 sequences (Fig. 1 B) is that NBD1 has a "regulatory insertion" consisting of amino acids 404435 (Lewis et al., 2004
, 2005
). Deletion of part of this regulatory insertion destabilizes the open state (Csanády et al., 2005
). Interestingly, two additional aromatic amino acids (F409 and F430) are located in this regulatory insertion. Furthermore, the crystal structure of NBD1 from mouse CFTR shows interactions between ATP and all three amino acids including W401, F409 (leucine in the mouse NBD1), and F430. Since multiple aromatic amino acids can be used to form a high affinity nucleotide binding pocket (e.g., Gillespie et al., 1999
; Huai et al., 2003
, 2004
), we further examine the contribution of F409 and F430 in stabilizing the open state.
We converted all three aromatic amino acids, including W401, F409, and F430 to glycine in the E1371S background and examined current relaxations of the W401G/F409G/F430G/E1371S (or triple/E1371S). Compared with the current relaxation of W401G/E1371S (Fig. 3 B), the triple/E1371S mutation further shortens the time course of current decay. Thus the relaxation time constants show a graded change as additional mutations in NBD1's ATP binding pocket were introduced (Fig. 3 C). The simplest interpretation of these results is that these three aromatic amino acids contribute to the stability of the open state by stabilizing ATP binding at the NBD1 site.
To further examine the role of ligand binding in stabilizing the open state, we considered nucleoside triphosphates that have been characterized previously, such as GTP, CTP, UTP (Zeltwanger, 1998
), and P-ATP (Zhou et al., 2005
). Unlike GTP, CTP, and UTP, which only change the apparent affinity modestly, P-ATP has an apparent affinity >50-fold of that for ATP. We thus consider P-ATP an ideal ATP analogue for this type of energetic analysis. If the hypothesis that ligand binding energy can contribute to the stability of the open state is correct, one would expect that P-ATP should prolong the open time constant (Fig. 4 A).
Fig. 4 B shows experiments examining current relaxations upon removal of ATP or P-ATP for E1371S, W401G/E1371S, Y1219G/E1371S, and triple/E1371S. As demonstrated previously (Zhou et al., 2005
), the relaxation time course upon washout of P-ATP for E1371S is approximately twofold longer than that with ATP. P-ATP also increases the relaxation time constant of Y1219G/E1371S by approximately twofold. However, this prolongation effect of P-ATP is significantly larger for W401G/E1371S (2.7-fold) and triple/E1371S (greater than fourfold; Fig. 4 C). These data suggest an energetic coupling between mutations at the NBD1 site and alterations of the bound ligand. On the other hand, mutating the NBD2 residue and changing of the binding energy of the ligand are two independent events (see online supplemental material for detailed analysis). We thus propose that ligand binding at the NBD1 site stabilizes the open state.
|
| DISCUSSION |
|---|
|
|
|---|
Recent successes in solving the crystal structures of CFTR's NBD1 (Lewis et al., 2004
, 2005
) have laid the foundation for a new era of gating studies using structure-guided mutagenesis approaches. The crystal structure of human CFTR's NBD1 reveals that the side chain of the W401 residue forms ringring stacking interaction with the adenine ring of the bound ATP molecule. Previous studies of other ATP binding proteins (MacLeod et al., 1998
; Zhao and Chang, 2004
; compare with Shyamala et al., 1991
) suggest that aromatic amino acids that interact with the adenine ring of ATP may be the ideal candidates for investigating the role of ATP binding. Although the crystal structure of CFTR's NBD2 has yet to be solved, using sequence analysis and homology modeling, we identified the Y1219 residue as the equivalent amino acid at the NBD2 site that interacts with the adenine ring of ATP (Fig. 1). A model by H. Senderowitz and collaborators from Predix Pharmaceuticals also reveals the same role of Y1219 in ATP binding (personal communication). Functional studies of the Y1219 mutations indeed suggest a critical role of this residue in channel opening (Figs. 1 and 2). The Y1219I mutation lowers the sensitivity of the opening rate to [ATP] without altering the maximal opening rate (Fig. 2), indicating that this mutation indeed decreases the binding affinity for ATP at the NBD2 site. Interestingly, although the Y1219G mutation causes a drastic shift of the ATP doseresponse relationship (Figs. 1 and 2), it does not affect the mean open time. If we accept the idea that the open time is determined by the rate of ATP hydrolysis (Gadsby et al., 2006
), this latter result suggests that the mutations at the Y1219 residue preferentially decrease ATP binding affinity without a significant effect on ATP hydrolysis. Thus, these novel mutations investigated in this paper could be useful tools to discern the roles of ATP binding for future CFTR gating studies.
Although the crystal structure of human CFTR's NBD1 reveals the importance of W401 in ATP binding at the NBD1 site, the W401 mutation does not affect the ATP doseresponse relationship, an inexact but direct way to estimate changes of ATP binding affinity. This negative result presents challenges for one to quantitatively gauge ATPNBD1 interactions. Our energetic analysis shown in the supplemental material, albeit imperfect and with its own assumptions, provides a potential quantitative assay to assess the functional consequence of mutations that decrease ATP binding affinity at the NBD1 site. Using this analysis, we show that two additional aromatic amino acids (F409 and F430) also play a role in determining the closing rate. It should be noted that F409 and F430 are found to interact with ATP in the crystal structure of mouse NBD1, but not human NBD1. The reason for this discrepancy is unclear. But X-ray crystallography provides only static snapshots of protein structures. Moreover, the numerous artificial mutations introduced into human CFTR's NBD1 for optimal crystallization may cause distortion of the structure. A more interesting possibility is that these minor differences in the binding pocket for the adenine ring of ATP may reflect different NBD1 structures in different functional states. Future studies of CFTR gating using these mutations may provide definitive answers.
The current studies of mutations in CFTR's ATP binding pockets suggest that the two ATP binding sites differ in their gating functions both kinetically and energetically. Since the closed state of the channel represents NBDs in the monomeric configuration (Vergani et al., 2005
), the relationship between [ATP] and the opening rate reflects the ATP binding affinity at the site that controls channel opening. Our results with the Y1219 and W401 mutations (Fig. 2 C) suggest that ATP binding at the NBD2 site, but not the NBD1 site, is critical for channel opening. However, whether ATP binding at the NBD1 site is essential for channel opening (e.g., Vergani et al., 2003
) remains unknown. On the other hand, although both ATP binding sites play a role in channel closing, each site utilizes ATP differently. During normal hydrolysis-driven gating, it appears that it is the ATP hydrolysis at the NBD2 site that catalyzes channel closing (Carson et al., 1995
; Zeltwanger et al., 1999
; Vergani et al., 2003
; Bompadre et al., 2005b
), whereas ATP binding at the NBD1 site modulates the closing rate by stabilizing the open channel conformation.
The kinetic and energetic asymmetry in CFTR's NBDs described above imparts several structural and biochemical implications. First, we propose an asymmetrical molecular motion of NBDs during gating. Our results suggest that channel opening is initiated by ATP binding at the NBD2 site. Indeed, the critical pair of amino acids (R555 and T1246 in Vergani et al., 2005
) identified for lowering the transitional state energy for NBD dimerization is absent in the NBD1 site (T460 and L1353). Thus, it is possible that the molecular motion of NBD dimerization that leads to opening of the gate may not proceed as a simple symmetrical movement of two ATP-bound NBDs. We propose that NBD dimerization is triggered by ATP binding at the NBD2 site and subsequently progresses to close the gap at the NBD1 site. Since the open state represents a head-to-tail dimer of CFTR's two NBDs with two ATP molecules sandwiched in between, the ligand ATP now becomes part of the whole protein molecule in the open channel configuration. Thus, the ligand binding energy is expected to be part of the overall energetics of the open channel conformation. This idea predicts that manipulating the ligand binding energy with mutations or alterations of ligands can affect the stability of the open state. It seems puzzling that mutations at the NBD1 site, but not the NBD2 site, affect the open time. However, these results are consistent with the idea that separation of the NBD dimer at the NBD1 site is coupled to channel closing (compare Vergani et al., 2003
). Taking one step further, we speculate that the molecular motion that couples NBD dimerization and opening of the gate resides in the NBD1 site.
Second, it is known that NBD1 does not hydrolyze ATP (Szabo et al., 1999
; Aleksandrov et al., 2002
; Basso et al., 2003
). Unlike the NBD2 site, the ATP binding pocket at NBD1 lacks the crucial glutamate residue that serves as a catalytic base for ATP hydrolysis (Lewis et al., 2004
, 2005
). In addition, the Walker A lysine (K464 in human CFTR) is not perfectly conserved across species. If the hypothesis that the free energy of ATP binding at the NBD1 site is used to stabilize the open channel configuration is correct, it is perhaps not surprising that the NBD1 site is not designed to hydrolyze ATP.
Third, to harvest a high binding energy at NBD1, it is necessary to construct a binding pocket that binds ATP tightly. It is interesting to note that the two aromatic residues, F409 and F430, in the ATP binding pocket of the NBD1 site, are located in the regulatory insertion that is unique to CFTR's NBD1. The existence of multiple aromatic residues in ATP binding pockets have been reported previously in many ATP binding proteins with high affinity to nucleotides, such as phosphodiesterases (Huai et al., 2003
, 2004
) and myosin isozymes (Gillespie et al., 1999
). It is tempting to speculate that the higher affinity for nucleotides in NBD1 compared with NBD2 (Szabo et al., 1999
; Aleksandrov et al., 2001
; Aleksandrov et al., 2002
; Basso et al., 2003
; Zhou et al., 2005
) is at least partly due to the existence of multiple aromatic residues in the ATP binding pocket of NBD1.
Regardless of how NBD1 assumes a high affinity for ATP, given the fact that the intracellular [ATP] is nearly always maintained in the millimolar range, it seems puzzling why one of CFTR's two NBDs (i.e., NBD1) exhibits a higher affinity for ATP, while most of the other ABC family members have two very similar NBDs. If we accept that CFTR is evolved from a primordial ABC transporter that functions as an ATP hydrolysisdriven pump, this structural modification of CFTR's NBD1 may serve a teleological purpose. For a pump molecule to transport its substrate efficiently, it is preferable for most of the intermediate states during a transport cycle to be short-lived. This basic design principle for efficient pumps may not be ideal for a channel because only the open state of the channel conducts ions. It seems possible that the purpose of rendering NBD1 with a high affinity for ATP is to allow the channel to stay in the open state longer so that more Cl ions can go through the channel during each gating cycle.
| ACKNOWLEDGMENTS |
|---|
R-CFTR construct, and Shenghui Hu and Cindy Chu for excellent technical assistance. This work was supported by NIHR01HL53445, DK55835 (T.C. Hwang), NIHK25DK61529 (X. Zou), and Research Grants from the Cystic Fibrosis Foundation (Z. Zhou and T.C. Hwang).
Olaf S. Andersen served as editor.
Submitted: 6 July 2006
Accepted: 24 August 2006
| REFERENCES |
|---|
|
|
|---|
R-CFTR). J. Gen. Physiol. 125:361375.This article has been cited by other articles:
![]() |
T.-C. Hwang and D. N. Sheppard Gating of the CFTR Cl\#8722; channel by ATP-driven nucleotide-binding domain dimerisation J. Physiol., May 15, 2009; 587(10): 2151 - 2161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. Tsai, H. Shimizu, Y. Sohma, M. Li, and T.-C. Hwang State-dependent modulation of CFTR gating by pyrophosphate J. Gen. Physiol., April 1, 2009; 133(4): 405 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Muallem and P. Vergani ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator Phil Trans R Soc B, January 27, 2009; 364(1514): 247 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, S. G. Bompadre, M. Li, and T.-C. Hwang Mutations at the Signature Sequence of CFTR Create a Cd2+-gated Chloride Channel J. Gen. Physiol., December 29, 2008; 133(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mio, T. Ogura, M. Mio, H. Shimizu, T.-C. Hwang, C. Sato, and Y. Sohma Three-dimensional Reconstruction of Human Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Revealed an Ellipsoidal Structure with Orifices beneath the Putative Transmembrane Domain J. Biol. Chem., October 31, 2008; 283(44): 30300 - 30310. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-Y. Chen and T.-C. Hwang CLC-0 and CFTR: Chloride Channels Evolved From Transporters Physiol Rev, April 1, 2008; 88(2): 351 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Bompadre, M. Li, and T.-C. Hwang Mechanism of G551D-CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Potentiation by a High Affinity ATP Analog J. Biol. Chem., February 29, 2008; 283(9): 5364 - 5369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Bompadre, Y. Sohma, M. Li, and T.-C. Hwang G551D and G1349D, Two CF-associated Mutations in the Signature Sequences of CFTR, Exhibit Distinct Gating Defects J. Gen. Physiol., March 26, 2007; 129(4): 285 - 298. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|